View in EDS

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.

Saved in:
Bibliographic Details
Title: NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.
Authors: de la Calle-Fabregat C; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Calafell-Segura J; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain., Gardet M; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Dunsmore G; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Mulder K; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Ciudad L; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain., Silvin A; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Moreno-Càceres J; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain., Corbí ÁL; Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain., Muñoz-Pinedo C; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain., Michels J; INSERM UMR1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Saclay, 94805 Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, 94805 Villejuif, France., Gouy S; Department of Surgical Oncology, Gustave Roussy, 94805 Villejuif, France., Dutertre CA; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Rodríguez-Ubreva J; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain., Ginhoux F; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Ballestar E; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.; Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai 200241, China.
Source: Science advances [Sci Adv] 2024 Sep 20; Vol. 10 (38), pp. eadq5226. Date of Electronic Publication: 2024 Sep 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39292770
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+la+Calle-Fabregat+C%22">de la Calle-Fabregat C</searchLink>; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Calafell-Segura+J%22">Calafell-Segura J</searchLink>; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gardet+M%22">Gardet M</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Dunsmore+G%22">Dunsmore G</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Mulder+K%22">Mulder K</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ciudad+L%22">Ciudad L</searchLink>; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Silvin+A%22">Silvin A</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Moreno-Càceres+J%22">Moreno-Càceres J</searchLink>; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Corbí+ÁL%22">Corbí ÁL</searchLink>; Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz-Pinedo+C%22">Muñoz-Pinedo C</searchLink>; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Michels+J%22">Michels J</searchLink>; INSERM UMR1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Saclay, 94805 Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Gouy+S%22">Gouy S</searchLink>; Department of Surgical Oncology, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Dutertre+CA%22">Dutertre CA</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Ubreva+J%22">Rodríguez-Ubreva J</searchLink>; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ginhoux+F%22">Ginhoux F</searchLink>; INSERM UMR1015, Gustave Roussy Cancer Campus, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ballestar+E%22">Ballestar E</searchLink>; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.; Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai 200241, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653440%22">Science advances</searchLink> [Sci Adv] 2024 Sep 20; Vol. 10 (38), pp. eadq5226. <i>Date of Electronic Publication: </i>2024 Sep 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101653440 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2375-2548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223752548%22">23752548 </searchLink><i>NLM ISO Abbreviation: </i>Sci Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39292770
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/sciadv.adq5226
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: eadq5226
    Titles:
      – TitleFull: NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de la Calle-Fabregat C
      – PersonEntity:
          Name:
            NameFull: Calafell-Segura J
      – PersonEntity:
          Name:
            NameFull: Gardet M
      – PersonEntity:
          Name:
            NameFull: Dunsmore G
      – PersonEntity:
          Name:
            NameFull: Mulder K
      – PersonEntity:
          Name:
            NameFull: Ciudad L
      – PersonEntity:
          Name:
            NameFull: Silvin A
      – PersonEntity:
          Name:
            NameFull: Moreno-Càceres J
      – PersonEntity:
          Name:
            NameFull: Corbí ÁL
      – PersonEntity:
          Name:
            NameFull: Muñoz-Pinedo C
      – PersonEntity:
          Name:
            NameFull: Michels J
      – PersonEntity:
          Name:
            NameFull: Gouy S
      – PersonEntity:
          Name:
            NameFull: Dutertre CA
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Ubreva J
      – PersonEntity:
          Name:
            NameFull: Ginhoux F
      – PersonEntity:
          Name:
            NameFull: Ballestar E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 09
              Text: 2024 Sep 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2375-2548
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 38
          Titles:
            – TitleFull: Science advances
              Type: main
ResultId 1